Clinical Trial Update: Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing paricalcitol to calcitriol for efficacy and safety in stage 3/4 chronic kidney disease with secondary hyperparathyroidism. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Calcitriol (calcitriol)
• Paricalcitol (paricalcitol)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-08-05